Pediatric low-grade gliomas are collectively the most common brain tumor of childhood. Thousands of children across the world are diagnosed with these tumors each year and are faced with significant effects from growth of the tumor, in addition to the treatments required to treat them.

The Pediatric Low-Grade Astrocytoma (PLGA) Program at Dana-Farber Cancer Institute formed in 2007 with the mandate to find more effective, less toxic treatments and a cure for children battling brain tumors. The program consists of families, friends, physicians, nurses and scientists all working together towards our common goal to improve outcomes for all children diagnosed with these devastating tumors.

Support PLGA Research

Low-grade astrocytomas are the most common form of pediatric brain cancer. Children diagnosed with these tumors are too frequently faced with life long effects from the tumors and their treatments.

Our team of research scientists and clinicians is working to identify targetable vulnerabilities in PLGAs, and to develop desperately needed new therapies that attack only cancer cells, leaving healthy cells unharmed.

Your gift will support our research and improve the outlook for pediatric PLGA patients.